Introduction Over the past 35 or more years, mature and immature allogeneic and autologous hematopoietic cells collected from the PB3 have been used in the supportive care management of patients with therapy or disease-induced intermittent, recurrent, and often prolonged periods of BM suppression. Clinical, laboratory, and technological research has been directed into the cellular contents of t...